Cardiol Therapeutics Inc.

Direct answer

Cardiol Therapeutics Inc. is publicly traded on TSX under the ticker CRDL.TO.

Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company, primarily engaged in the discovery and advancement of treatments designed to combat fibrosis and inflammation within the context of cardiovascular diseases. Its flagship product, CardiolRx, is currently undergoing a significant Phase II/III international clinical trial. This extensive study is randomized, double-blind, and...

Can you invest in Cardiol Therapeutics Inc.?

Yes. Cardiol Therapeutics Inc. is publicly traded on TSX under the ticker CRDL.TO.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Cardiol Therapeutics Inc.

Detailed equity research is provided by MarketSnap.